Atypical antipsychotics in the treatment of schizophrenia - Validity of dropout rates as proxy measure of tolerability is unknown

被引：0

作者：

Rowsell, R ^{[1
]}

Link, C ^{[1
]}

Donoghue, J ^{[1
]}

机构：

[1] AstraZeneca UK, Kings Langley WD4 8DH, Herts, England

来源：

BRITISH MEDICAL JOURNAL | 2001年 / 322卷 / 7291期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：925 / 925

页数：1

共 50 条

[41] Inpatient treatment of schizophrenia:: A study of two leading atypical antipsychotics
Laux, G
König, W
Jones, M
SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 38 - 38
[42] Relapse rates in patients with schizophrenia receiving aripipyazole in comparison with other atypical antipsychotics
Moeller, Karen E.
Shireman, Theresa I.
Liskow, Barry I.
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (12) : 1942 - 1947
[43] Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review (vol 9, pg 683, 2010)
Canas, F.
Moeller, H.-J.
EXPERT OPINION ON DRUG SAFETY, 2010, 9 (06) : 1007 - 1007
[44] Role of newer atypical antipsychotics in the management of treatment-resistant schizophrenia
Emsley, RA
CNS DRUGS, 2000, 13 (06) : 409 - 420
[45] Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia
Lindenmayer, JP
Czobor, P
Volavka, J
Lieberman, JA
Citrome, L
Sheitman, B
McEvoy, JP
Cooper, TB
Chakos, M
JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (04) : 551 - 556
[46] Advances in atypical antipsychotics for the treatment of schizophrenia - New formulations and new agents
Kelleher, JP
Centorrino, F
Albert, MJ
Baldessarini, RJ
CNS DRUGS, 2002, 16 (04) : 249 - 261
[47] Long-term treatment persistence with atypical antipsychotics in schizophrenia.
Hodgson, RE
MacKenzie, G
Belgamwar, R
Al-tawarab, Y
JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) : A57 - A57
[48] Role of Newer Atypical Antipsychotics in the Management of Treatment-Resistant Schizophrenia
Robin A. Emsley
CNS Drugs, 2000, 13 : 409 - 420
[49] THE USAGE OF THE ATYPICAL ANTIPSYCHOTICS IN TREATMENT OF SCHIZOPHRENIA WITH OBSESSIVE-COMPULSIVE SYMPTOMS
Reznik, I.
Yadin, S.
Weizman, A.
EUROPEAN PSYCHIATRY, 2012, 27
[50] Modifying the risk of atypical antipsychotics in the treatment of juvenile-onset schizophrenia
Townsend, Lisa
Findling, Robert L.
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (02) : 195 - 205

← 1 2 3 4 5 →